thymosin alpha 1 peptide​

Price range: $80.00 through $180.00

Thymosin Alpha 1 Dosage Protocols for Research

Since thymosin alpha 1 is not approved for human use in all countries, dosage guidelines are based on preclinical and clinical research models. Researchers should adjust protocols based on study objectives.

General Dosage Guidelines

Study Type Dosage Range Administration Route Frequency
Infectious Disease 1.6–3.2 mg Subcutaneous (SC) or Intravenous (IV) Daily for 7–28 days
Cancer Immunotherapy 1.6–6.4 mg SC or IV 2–3x per week for 4–12 weeks
Autoimmune Disorders 1.6–3.2 mg SC Daily or every other day for 4–12 weeks
Aging & Immunosenescence 1.6 mg SC 2–3x per week for 8–12 weeks
Neurodegenerative Diseases 1.6–3.2 mg SC or IP (intraperitoneal) Daily for 4–8 weeks

Key Dosage Considerations

✔ Start with low doses (1.6 mg) to assess immune response.
✔ Monitor cytokine levels (to avoid overstimulation).
✔ Use intermittent dosing for long-term studies (to prevent tolerance).
✔ Consider combination therapies (e.g., with interferons or checkpoint inhibitors).

Where to Buy High-Quality Thymosin Alpha 1 for Research

For researchers seeking pharmaceutical-grade thymosin alpha 1 peptideWholesale China Peptides offers:
✅ ≥98% Purity (HPLC-verified)
✅ Lyophilized for long-term stability
✅ Batch-specific COAs (Certificate of Analysis)
✅ Bulk & wholesale pricing for institutions
✅ Secure, discreet shipping worldwide

Note: Thymosin alpha 1 is for research use only—not for human consumption, medical treatment, or performance enhancement.